DNA: Ginkgo Bioworks Holdings, Inc.
Performance
DNA +38.21%
Watchlist
Select an item
Summary
DNA at a glance
DNA returned +38.21% over the past year and -53.22% a year over five years. Its worst drop in that year was -48.78%, smaller than 24% of stocks on Redstone, and its Sharpe ratio of 0.80 beats 66% of stocks on Redstone. It pays no dividends.
Current Drawdown
-17.42%
Rolling Volatility
143.38%
Actions
Metrics
Risk Indicators
Alpha49.45%
Beta3.29x
Sharpe0.80
Sortino1.22
Omega1.15
Calmar0.78
Martin3.46
Profile
About DNA
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $833M
- Listed
- Apr 2021
- Employees
- 485
- Headquarters
- Boston, MA
- Website
- ginkgobioworks.com
Comparisons